Výsledky vyhledávání - "Rachel Montgomery"

Real-World Treatment Patterns Among Patients With Metastatic Castration-Resistant Prostate Cancer: Results From an International Study

Autor: Pedro C Barata, Andrea Leith, Amanda Ribbands, Rachel Montgomery, Matthew Last, Bhakti Arondekar, Jasmina Ivanova, Alexander Niyazov

Publikováno v: The Oncologist.

Background There is limited real-world evidence on how increasing use of treatment intensification in metastatic castration-sensitive prostate cancer (mCSPC) has influenced treatment decisions in metastatic castration-resistant prostate cancer (mCRPC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::db65aec8242f2097ba9fe21cec60465a
https://doi.org/10.1093/oncolo/oyad046

Zobrazit plný text záznamu

Real-World Treatment Trends Among Patients with Metastatic Castration-Sensitive Prostate Cancer: Results from an International Study

Autor: Pedro C Barata, Andrea Leith, Amanda Ribbands, Rachel Montgomery, Matthew Last, Bhakti Arondekar, Jasmina Ivanova, Alexander Niyazov

Publikováno v: The Oncologist.

Background Continuous androgen deprivation therapy ± first-generation non-steroidal antiandrogen was previously the standard-of-care for patients with metastatic castration-sensitive prostate cancer (mCSPC). Treatment intensification with novel horm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6508d5d613a64c5bce91b2c89384cdaa
https://doi.org/10.1093/oncolo/oyad045

Zobrazit plný text záznamu

Real-world homologous recombination repair (HRR) mutation testing patterns in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) in the United States (US)

Autor: Pedro C. Barata, Rachel Montgomery, Matthew Last, Liane Gillespie-Akar, Jonathan Nazari, Alexander Niyazov

Publikováno v: Journal of Clinical Oncology. 41:99-99

99 Background: A subset of pts with metastatic prostate cancer have HRR mutations. These can be either germline or somatic mutations. Previous studies have established a prognostic and predictive role of HRR mutations and there are ongoing trials (e.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b3bbb52c86740b0d4e9976ad17bae6cd
https://doi.org/10.1200/jco.2023.41.6_suppl.99

Zobrazit plný text záznamu

An RF timer of electrons and photons with the potential to reach picosecond precision

Publikováno v: Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 1038:166926

This paper describes a new radio frequency timer of keV energy electrons. It is based on a helical deflector, which performs circular or elliptical sweeps of keV electrons, by means of 500 MHz radio frequency field. By converting a time distribution

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65dc69c33e7b5c0a70b864c6641ee23a
https://doi.org/10.1016/j.nima.2022.166926

Zobrazit plný text záznamu

Treatment (tx) patterns among men with metastatic castration resistant prostate cancer (mCRPC) in the United States (US)

Autor: Pedro C. Barata, Andrea Leith, Amanda Ribbands, Rachel Montgomery, Matthew Last, Bhakti Arondekar, Alexander Niyazov, Jasmina Ivanova

Publikováno v: Journal of Clinical Oncology. 40:52-52

52 Background: Novel hormonal therapies (NHTs) and docetaxel were initially approved for the tx of men with mCRPC. Over time, these agents moved earlier in the disease continuum and are now also used in metastatic castration sensitive prostate cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9bd36b329ccbf4fa52203cd003f57cf5
https://doi.org/10.1200/jco.2022.40.6_suppl.052

Zobrazit plný text záznamu

Criteria used to determine platinum eligibility and first-line (1L) treatment (tx) patterns among platinum-eligible (PE) and -ineligible (PI) patients (pts) with metastatic urothelial cancer (mUC) in France, Germany, Spain, Italy, and the United Kingdom (Eu5)

Autor: Neil Milloy, Melissa Kirker, Mia Berry, Michael Kostikas, Rachel Montgomery, Mairead Kearney, Nuno Matos Costa, Jane Chang

Publikováno v: Journal of Clinical Oncology. 40:457-457

457 Background: European Society for Medical Oncology (ESMO) guidelines recommend tx for mUC based on cisplatin and platinum eligibility. To date, most real-world analyses have not included physician-confirmed eligibility status. This study collected

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8ae2d2965b35e255962d11d653aae06c
https://doi.org/10.1200/jco.2022.40.6_suppl.457

Zobrazit plný text záznamu

Use of perioperative treatment (tx) among patients (pts) undergoing radical resection (RR) for muscle-invasive urothelial cancer (MIUC) in France, Germany, Italy, Spain, the United Kingdom, the United States, Canada, China, and Japan

Autor: Edward I Broughton, Jürgen E. Gschwend, J. Alfred Witjes, Mia Berry, Michael Kostikas, Rachel Montgomery, Annabel Lambert, Siguroli Teitsson, Neil Milloy

Publikováno v: Journal of Clinical Oncology. 40:467-467

467 Background: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by RR is the standard of care in cisplatin-eligible pts with MIUC. Adjuvant chemotherapy (AC) with cisplatin-based tx may be offered to those not given NAC. The unmet need this s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::eaba7378bd327af2c5f445907cd1f84c
https://doi.org/10.1200/jco.2022.40.6_suppl.467

Zobrazit plný text záznamu

Treatment trends among men with metastatic castration sensitive prostate cancer (mCSPC): Results from the US component of an international study

Autor: Pedro C. Barata, Andrea Leith, Amanda Ribbands, Rachel Montgomery, Matthew Last, Bhakti Arondekar, Alexander Niyazov, Jasmina Ivanova

Publikováno v: Journal of Clinical Oncology. 40:66-66

66 Background: Novel hormonal therapies (NHTs) and taxane-based chemotherapy (CT) were initially approved for the treatment of metastatic castration resistant prostate cancer (mCRPC) and are now approved for use in mCSPC. Little is known about the re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::742de3d963c7d1bfc4222fe76877ce4a
https://doi.org/10.1200/jco.2022.40.6_suppl.066

Zobrazit plný text záznamu

UK trends of allergic occupational skin disease attributed to fragrances 1996-2015

Autor: Raymond Agius, S. M. Wilkinson, Melanie Carder, Rachel Montgomery

Publikováno v: Contact Dermatitis. 78:33-40

SummaryBackground Fragrances are well known to cause allergic contact dermatitis (ACD). Occupationally related cases occur, with certain groups being at higher risk. Objective To investigate the incidence of occupationally related cases of cutaneous

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c1f58ea5a1765e6101ca16b0afdac3d2
https://doi.org/10.1111/cod.12902

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání